First, we identified a common deletion in H23, OVCAR3, and A2780 cells induced by cisplatin treatment in chromosome 18, including two completely deleted genes, LRP1B, and ITF2. A similar deletion was identified in a previous study analyzing cisplatin response in ovarian cancer samples, which supports our results [16]. This evidence concerns the gene LRP1B and ovarian carcinoma.